v3.26.1
Segment Information - Reconciliation of Segment Adjusted EBITDA to Net income (loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information    
Revenues $ 585.5 $ 593.7
People-related costs (202.2) (205.7)
Royalties and other product costs (69.8) (81.9)
Technology costs (40.4) (38.9)
Outside service costs (13.5) (17.4)
Other costs (18.4) (16.6)
Adjusted EBITDA 241.2 233.2
Provision (benefit) for income taxes (11.4) (18.8)
Depreciation and amortization (184.0) (185.4)
Interest expense, net (59.0) (64.3)
Share-based compensation expense (14.6) (11.1)
Restructuring costs (12.0) (24.7)
Transaction related costs (8.2) (6.3)
Other 7.8 (26.5)
Net income (loss) (40.2) (103.9)
Academia & Government    
Segment Reporting Information    
Revenues 295.0 302.7
People-related costs (85.3) (86.2)
Royalties and other product costs (45.1) (55.1)
Technology costs (21.0) (19.6)
Outside service costs (7.3) (9.1)
Other costs (9.7) (8.9)
Adjusted EBITDA 126.6 123.8
Restructuring costs (4.8) (12.3)
Intellectual Property    
Segment Reporting Information    
Revenues 197.2 192.7
People-related costs (73.2) (72.7)
Royalties and other product costs (15.9) (18.0)
Technology costs (12.8) (12.3)
Outside service costs (4.2) (5.7)
Other costs (5.7) (5.2)
Adjusted EBITDA 85.4 78.8
Restructuring costs (4.1) (6.5)
Life Sciences & Healthcare    
Segment Reporting Information    
Revenues 93.3 98.3
People-related costs (43.7) (46.8)
Royalties and other product costs (8.8) (8.8)
Technology costs (6.6) (7.0)
Outside service costs (2.0) (2.6)
Other costs (3.0) (2.5)
Adjusted EBITDA 29.2 30.6
Restructuring costs $ (3.1) $ (5.9)